The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap.
For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2020 Range: (62.94 – 121.33)
Get this week and next week’s XBI Options Trade Forecast view by clicking here
Weekly Chart
Daily Chart
5 Day Chart
Get the XBI Monthly and LEAP Options Trade Forecast view by clicking here
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 14 Day RSI at 80% | 146.79 | |
| 14 Day RSI at 70% | 129.58 | |
| 13-Week High | 122.82 | |
| 52-Week High | 122.82 | |
| 1-Month High | 122.82 | |
| Last | 117.63 | Last |
| 116.35 | 38.2% Retracement From 4 Week High | |
| 115.81 | 14 Day RSI at 50% | |
| 114.35 | 38.2% Retracement From 13 Week High | |
| 114.35 | 50% Retracement From 4 Week High/Low | |
| 112.36 | 38.2% Retracement From 4 Week Low | |
| 111.73 | 50% Retracement From 13 Week High/Low | |
| 109.11 | 38.2% Retracement From 13 Week Low | |
| 1-Month Low | 105.89 | |
| 13-Week Low | 100.64 | |
| 99.95 | 38.2% Retracement From 52 Week High | |
| 14 Day RSI at 30% | 99.62 | |
| 92.88 | 50% Retracement From 52 Week High/Low | |
| 85.81 | 38.2% Retracement From 52 Week Low | |
| 14 Day RSI at 20% | 79.37 | |
| 52-Week Low | 62.94 |
